8 recruiting, 6 not yet recruiting, 4 unknown, 3 active not recruiting. 24 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 24 | Recruiting 8, Not yet recruiting 6, Unknown 4, Active not recruiting 3, Completed 2, Enrolling by invitation 1 |
Follow Neoadjuvant Therapy: new trials by email Literature Review of Neoadjuvant Therapy trials Research Report on Neoadjuvant Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adaptive Neoadjuvant Therapy for Esophageal Cancer Neoadjuvant concurrent chemoradiotherapy - Esophageal Carcinoma, Neoadjuvant Therapy | Not applicable | Enrolling by invitation | Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | 43 | 2028-03-01 | 2025-05-25 |
| Impact of Routine Electronic Patient-Reported Outcome (ePRO)Symptom Monitoring During Neoadjuvant Therapy in Patients withPancreatic Adenocarcinoma on Patient Experience and ClinicalOutcomes: A Prospective Pre-Post Implementation Study Standard of Care - ePRO, Symptom Monitoring | Not applicable | Not yet recruiting | M.D. Anderson Cancer Center | 200 | 2027-02-21 | 2026-09-21 |
| Neoadjuvant Iruplinalkib and Bevacizumab in ALK-positive NSCLC: A Phase II Single-arm Trial Bevacizumab combined with iruplinalkib as neoadjuvant therapy in ALK-positive NSCLC: - ALK, NSCLC | Not applicable | Not yet recruiting | Shanghai Pulmonary Hospital, Shanghai, China | 40 | 2026-09-15 | 2026-10-13 |
| MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer Adaptive therapy of de-escalation and escalation based on MRD testing and pathological response - Lung Neoplasms, Neoadjuvant Therapy | Not applicable | Recruiting | Peking University People's Hospital | 100 | 2026-08-12 | 2026-10-26 |
| Oral Paclitaxel as Neoadjuvant Therapy in Elderly NSCLC: A Phase II Trial Paclitaxel Oral Solution - Non-Small-Cell Lung Cancer, Neoadjuvant Therapy | Not applicable | Not yet recruiting | Shanghai Pulmonary Hospital, Shanghai, China | 75 | 2026-06-08 | 2026-05-20 |
| Digital Mind-Body Therapy for Neoadjuvant Breast Cancer DMBT - Neoadjuvant Therapy | Not applicable | Recruiting | Fudan University | 66 | 2026-03-25 | 2026-04-21 |
| Family-Supervised Prehabilitation to Reduce Postoperative Complications After Neoadjuvant Chemotherapy in Gastric Cancer Family-supervised Multimodal Prehabilitation, Standard Care - Stomach Neoplasms, Neoadjuvant Therapy | Not applicable | Not yet recruiting | The Affiliated Hospital of Qingdao University | 90 | 2025-09-20 | 2025-09-19 |
| Simple Surgical Glove Compression to Prevent Chemotherapy-Induced Peripheral Neuropathy Simple Surgical Glove Compression Technique - Breast Cancer, Chemotherapy Induced Peripheral Neuropathy (CIPN) | Not applicable | Not yet recruiting | Jinsong Lu | 44 | 2025-09-15 | 2025-09-12 |
| Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer Cemiplimab, Dupilumab - Non-Small Cell Lung Cancer, Immunotherapy | Not applicable | Recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 24 | 2025-08-19 | 2026-08-17 |
| Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study Digital self-management program - Breast Cancer, Colorectal Cancer (CRC) | Not applicable | Recruiting | Mälardalen University | 210 | 2025-03-01 | 2026-10-01 |
| Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy Question prompt list - Breast Cancer Early Stage Breast Cancer (Stage 1-3), Neoadjuvant Therapy | Not applicable | Recruiting | Region Örebro County | 218 | 2025-03-01 | 2025-04-20 |
| Application of Targeted Axillary Lymph Node Resection in Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: an Open-label, Multicenter Study carbon suspension - Breast Cancer Surgery, Neoadjuvant Therapy | Not applicable | Active not recruiting | Fujian Medical University Union Hospital | 175 | 2024-12-09 | 2025-06-22 |
| Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer Neoadjuvant therapy + vitamin D2, Neoadjuvant therapy - Vitamin D, Neoadjuvant Therapy | Not applicable | Recruiting | Jiuda Zhao | 140 | 2024-10-18 | 2025-01-17 |
| Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma Living donor liver transplantation - Living Donor Liver Transplantation, Liver Transplantation | Not applicable | Not yet recruiting | Jena University Hospital | 6 | 2024-09-01 | 2024-08-06 |
| The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer standard long-term therapy, FOLFOX and standard long-term radiotherapy, FOLFIRI and standard long-term radiotherapy - Neoadjuvant Therapy | Not applicable | Unknown | Shanghai Minimally Invasive Surgery Center | 192 | 2023-01-01 | 2022-04-28 |
| Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC Reducing Excision Margins - Squamous Cell Carcinoma of Head and Neck, Neoadjuvant Therapy | Not applicable | Active not recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 54 | 2022-06-22 | 2022-07-15 |
| Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy CEUS, blue dye - Breast Neoplasms, Neoadjuvant Therapy | Not applicable | Unknown | First Affiliated Hospital, Sun Yat-Sen University | 350 | 2021-06-15 | 2021-06-21 |
| Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy Radioactive Isotope (RI) Mapping, Indocyanine Green Fluorescence (ICG-F) Mapping, Vital Dye Mapping - Sentinel Lymph Node Biopsy, Neoadjuvant Therapy | Not applicable | Completed | National Cancer Center, Korea | 348 | 2021-05-04 | 2025-03-13 |
| Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases Physical Prehabilitation - Prehabilitation, Neoadjuvant Therapy | Not applicable | Recruiting | Institut Investigacio Sanitaria Pere Virgili | 84 | 2021-02-01 | 2024-07-01 |
| Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer multi-points and full-thickness Biopsy, traditional cCR - Rectal Cancer, Neoadjuvant Therapy | Not applicable | Recruiting | Beijing Chao Yang Hospital | 260 | 2021-01-01 | 2023-02-21 |
Showing 20 of 24. Sign in to see all of them.
Breast Neoplasms (9) · Carcinoma, Non-Small-Cell Lung (2) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Lung Neoplasms (1) · Margins of Excision (1) · Neoplasm Metastasis (1) · Neoplasm, Residual (1) · Pancreatic Neoplasms (1) · Pathologic Complete Response (1) · Postoperative Complications (1) · Prostatic Neoplasms (1) · Rectal Neoplasms (1) · Sedentary Behavior (1)
Neoplasms (18) · Neoplasms by Site (17) · Breast Diseases (9) · Skin Diseases (9) · Skin and Connective Tissue Diseases (9) · Digestive System Diseases (5) · Digestive System Neoplasms (5) · Gastrointestinal Diseases (4) · Gastrointestinal Neoplasms (4) · Pathological Conditions, Signs and Symptoms (4) · Lung Diseases (3) · Pathologic Processes (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Thoracic Neoplasms (3)
Neoadjuvant Therapy (2) · Standard of Care (2) · 130-nm albumin-bound paclitaxel (1) · Ergocalciferols (1) · Fluorouracil (1) · Folfox protocol (1) · Geriatric Assessment (1) · Paclitaxel (1) · Psychosocial Intervention (1) · cemiplimab (1) · dupilumab (1) · pembrolizumab (1)
Fudan University (2) · Fujian Medical University Union Hospital (2) · Shanghai Pulmonary Hospital, Shanghai, China (2) · Beijing Chao Yang Hospital (1) · Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center (1) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · Erasmus Medical Center (1) · First Affiliated Hospital, Sun Yat-Sen University (1) · Institut Investigacio Sanitaria Pere Virgili (1) · Jena University Hospital (1) · Jinsong Lu (1) · Jiuda Zhao (1) · M.D. Anderson Cancer Center (1) · Mälardalen University (1) · National Cancer Center, Korea (1)
China (13) · Sweden (2) · Canada (1) · Netherlands (1) · South Korea (1) · Spain (1) · United States (1)
Antoine Desilets, MD, MSc (1) · Antonis Valachis, MD, PhD (1) · China Fujian (1) · Chuan Wang (1) · Ernest JT Luiten, MD, PhD (1) · Falk Rauchfuss, Prof (1) · Jing Sun, PhD (1) · Laia Estalella, PhD (1) · Laura Schwenk, MD (1) · Linetta B Koppert, MD, PhD (1) · Marjolein L Smidt, MD, PhD (1) · Rebecca A Snyder, MD (1) · Seeyoun Lee, Doctor (1) · Tao Zhen Yu, MD (1)
PMID 16982773, PMID 17960012, PMID 18784101, PMID 21233014, PMID 21437225, PMID 23683750, PMID 24780112, PMID 25049329, PMID 25452445, PMID 28189914, PMID 28490940, PMID 28533474, PMID 29658848, PMID 29658856, PMID 30280658, PMID 30742122, PMID 31679945, PMID 33515668, PMID 33538338, PMID 38057662, PMID 39302345
2025 (1)